Repligen Corporation
Repligen Corporation（RGEN）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
rgen · 股价预测 · 24 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 24 位华尔街分析师
Buy
24 位分析师
共识
评级分布
12 个月目标价
High
$200
Consensus
$163
+33.4% upside
Low
$142
Median: $160 · Last Close: $122.31
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$163.14
33.4% upside
High Target
$200
63.5%
Low Target
$142
16.1%
Current Price
$122.31
as of today
Based on analyst price targets, the RGEN stock price prediction for the next 12 months ranges from $142 to $200. The consensus RGEN price forecast of $163.14 implies 33.4% upside from the current price of $122.31.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $127.50 | ↑ 4.25% |
1-day model range: $126.75–$128.26. Peak: $128.26 (+4.25%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $101 | -17.8% |
| 2028 | $90 | -26.6% |
| 2029 | $84 | -31.3% |
| 2030 | $81 | -33.9% |
| 2031 | — | -35.4% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RGEN · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-03 | HSBC | Maintains | Buy→Buy |
| 2026-05-06 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-05-06 | Barclays | Maintains | Overweight→Overweight |
| 2026-04-20 | Canaccord Genuity | Maintains | Hold→Hold |
| 2026-04-14 | Barclays | Maintains | Overweight→Overweight |
| 2026-04-06 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-03-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-25 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-02-25 | Barclays | Maintains | Overweight→Overweight |
| 2026-02-25 | UBS | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Repligen Corporation (RGEN) stock. Of the recent 107 rating actions, 6 were upgrades and 2 were downgrades. 24 analysts currently cover RGEN.
分析师推荐趋势
RGEN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$823M
↓ 24.2% YoY
Revenue Next Year
$945M
↑ 14.9% YoY
EPS This Year
$2.00
EPS Next Year
$2.58
↑ 29.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast RGEN EPS of $2.00 for the current fiscal year, based on estimates from 12 analysts. The RGEN revenue forecast is $823M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
RGEN 股价预测由两类独立数据源支撑：来自 24 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。RGEN 的共识目标价为 $163.14（+33.4% 上行空间），分析师共识为 Buy。
RGEN 的短期预测（明日）为 $127.50（+4.25%）。 RGEN 对 2027 年的股价预测均值为 $101。 RGEN 对 2030 年的预测区间为 $76–$86。
Repligen Corporation 在 NASDAQ 上市，代码 RGEN。RGEN 在 2027 年的整体展望偏积极，在覆盖分析师中约 88% 对应 Buy 共识。
常见问题
RGEN 预测 · 8 个问题根据 24 位华尔街分析师，RGEN 的 12 个月平均目标价为 $163.14，最高 $200.00、最低 $142.00。若有图表，中位目标价可在上方查看。相对当前价 $122.31，隐含约 +33.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.